We are live on ! Find out more
TTNP

Titan Pharmaceuticals
TTNP

Delisted

TTNP was delisted on the 1st of October, 2025.

Back to rankings

16 hedge funds and large institutions have $1.15M invested in Titan Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more capital invested

Capital invested by funds: $795K → $1.15M (+$352K)

0.01% more ownership

Funds ownership: 0% → 0.01% (+0.01%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

30% less funds holding

Funds holding: 23 → 16 (-7)

88% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 8

Holders
16
Holders Change
-7
Holders Change %
-30.43%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
8
Calls
$37K
Puts
–
Net Calls
+$37K
Net Calls Change
-$47K

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$1.25M
2
Citadel Advisors
Citadel Advisors
Florida
+$926

Top Sellers

Rank Fund Capital Flow
1
PAG
Private Advisor Group
New Jersey
-$65K
2
VF
Virtu Financial
New York
-$44K
3
UBS Group
UBS Group
Switzerland
-$29K
4
Jane Street
Jane Street
New York
-$7K
5
PA
Pinnacle Associates
New York
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$803K +$1.25M +8,095 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$190K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$85K – – –
Northern Trust
4
Northern Trust
Illinois
$32K – – –
Citadel Advisors
5
Citadel Advisors
Florida
$28K +$926 +6 +2%
CWM
6
Cornerstone Wealth Management
Missouri
$6K – – –
UBS Group
7
UBS Group
Switzerland
$1K -$29K -188 -97%
Bank of America
8
Bank of America
North Carolina
$1K – – –
Group One Trading
9
Group One Trading
Illinois
$1K – – –
APA
10
American Portfolios Advisors
New York
$103 – – –
WIM
11
Westside Investment Management
California
$1 – – –
PAG
12
Private Advisor Group
New Jersey
– -$65K -352 Closed
VF
13
Virtu Financial
New York
– -$44K -238 Closed
Jane Street
14
Jane Street
New York
– -$7K -39 Closed
PA
15
Pinnacle Associates
New York
– -$6K -33 Closed
TI
16
tru Independence
Oregon
– -$4 -26 Closed
PA
17
Procyon Advisors
Connecticut
– -$2K -8 Closed
Simplex Trading
18
Simplex Trading
Illinois
– -$463 -3 Closed

TTNP Hedge Fund Activity: Q3 2020 in Review

16 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Titan Pharmaceuticals (TTNP) for Q3 2020, worth a combined $1.15M — up 44% from $795K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of TTNP and 1 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Sabby Management, opening a new position worth an estimated $1.25M. The largest seller was Private Advisor Group, exiting entirely with an estimated $65K sold.

  • 16 institutional investors held Titan Pharmaceuticals (TTNP) as of Q3 2020, down from 23 in Q2 2020.
  • Funds reported $1.15M of Titan Pharmaceuticals stock for Q3 2020, up 44% quarter-over-quarter.
  • 1 fund opened new Titan Pharmaceuticals positions in Q3 2020 and 8 closed out, a net change of -7 holders.
  • The largest Titan Pharmaceuticals buyer in Q3 2020 was Sabby Management, an estimated $1.25M added.
  • The largest Titan Pharmaceuticals seller in Q3 2020 was Private Advisor Group, an estimated $65K sold.

Based on aggregated 13F filings for Q3 2020.